-
1
-
-
0033632236
-
The origin of the dispute over the discovery of heparin
-
Marcum JA. The origin of the dispute over the discovery of heparin. J Hist Med Allied Sci. 2000, 55:37-66.
-
(2000)
J Hist Med Allied Sci.
, vol.55
, pp. 37-66
-
-
Marcum, J.A.1
-
2
-
-
34250351975
-
Nonspecific electrostatic binding characteristics of the heparin-antihrombin interaction
-
Seyrek E, Dubin PL, Henriksen J. Nonspecific electrostatic binding characteristics of the heparin-antihrombin interaction. Biopolymers. 2007, 86:249-59.
-
(2007)
Biopolymers.
, vol.86
, pp. 249-259
-
-
Seyrek, E.1
Dubin, P.L.2
Henriksen, J.3
-
3
-
-
0034641729
-
Heparin sequencing brings structure to the function of complex oligosaccharides
-
Nugent MA. Heparin sequencing brings structure to the function of complex oligosaccharides. Proc Natl Acad Sci USA. 2000, 97:10301-3.
-
(2000)
Proc Natl Acad Sci USA.
, vol.97
, pp. 10301-10303
-
-
Nugent, M.A.1
-
4
-
-
0036463453
-
Novel drug development opportunities for heparin
-
Lever R, Page CP. Novel drug development opportunities for heparin. Nat Rev Drug Discov. 2002, 1:140-8.
-
(2002)
Nat Rev Drug Discov.
, vol.1
, pp. 140-148
-
-
Lever, R.1
Page, C.P.2
-
5
-
-
46749113163
-
The anti-inflammatory effects of heparin and related compounds
-
Young E. The anti-inflammatory effects of heparin and related compounds. Thromb Res. 2008, 122:743-52.
-
(2008)
Thromb Res.
, vol.122
, pp. 743-752
-
-
Young, E.1
-
6
-
-
0034126392
-
Heparin and related molecules as a new treatment for asthma
-
Diamant Z, Page CP. Heparin and related molecules as a new treatment for asthma. Pulm Pharmacol Ther. 2000, 13:1-4.
-
(2000)
Pulm Pharmacol Ther.
, vol.13
, pp. 1-4
-
-
Diamant, Z.1
Page, C.P.2
-
7
-
-
33847291915
-
Mechanisms of heparin induced anti-cancer activity in experimental cancer models
-
Niers TM, Klerk CP, DiNisio M. Mechanisms of heparin induced anti-cancer activity in experimental cancer models. Crit Rev Oncol Hematol. 2007, 61:195-207.
-
(2007)
Crit Rev Oncol Hematol.
, vol.61
, pp. 195-207
-
-
Niers, T.M.1
Klerk, C.P.2
DiNisio, M.3
-
8
-
-
52049121633
-
Antimetastatic effect of an orally active heparin derivative on experimentally induced metastasis
-
Lee DY, Park K, Kim SK. Antimetastatic effect of an orally active heparin derivative on experimentally induced metastasis. Clin Cancer Res. 2008, 14:2841-9.
-
(2008)
Clin Cancer Res.
, vol.14
, pp. 2841-2849
-
-
Lee, D.Y.1
Park, K.2
Kim, S.K.3
-
10
-
-
32844454747
-
Diversity-oriented chemical modification of heparin: identification of charge-reduced N-acyl heparin derivatives having increased selectivity for heparin-binding proteins
-
Huang L, Kerns RJ. Diversity-oriented chemical modification of heparin: identification of charge-reduced N-acyl heparin derivatives having increased selectivity for heparin-binding proteins. Bioorg Med Chem. 2006, 14:2300-13.
-
(2006)
Bioorg Med Chem.
, vol.14
, pp. 2300-2313
-
-
Huang, L.1
Kerns, R.J.2
-
11
-
-
0035912864
-
Guide to anticoagulant therapy: heparin-a statement for healthcare professionals from the American Heart Association
-
Hirsh J, Anand SS, Halperin JL. Guide to anticoagulant therapy: heparin-a statement for healthcare professionals from the American Heart Association. Circulation. 2001, 103:2994-3018.
-
(2001)
Circulation.
, vol.103
, pp. 2994-3018
-
-
Hirsh, J.1
Anand, S.S.2
Halperin, J.L.3
-
12
-
-
4644308426
-
Heparin and low-molecular-weight heparin: the seventh ACCP conference on antithrombotic and thrombolytic therapy
-
Hirsh J, Raschke R. Heparin and low-molecular-weight heparin: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004, 126:188S-203S.
-
(2004)
Chest.
, vol.126
-
-
Hirsh, J.1
Raschke, R.2
-
13
-
-
0033374678
-
Cell adhesion: old and new questions
-
Hynes RO. Cell adhesion: old and new questions. Trends Cell Biol. 1999, 9:33-7.
-
(1999)
Trends Cell Biol.
, vol.9
, pp. 33-37
-
-
Hynes, R.O.1
-
15
-
-
0026598574
-
Intercellular communication and cell-cell adhesion
-
Singer SJ. Intercellular communication and cell-cell adhesion. Science. 1992, 255:1671-7.
-
(1992)
Science.
, vol.255
, pp. 1671-1677
-
-
Singer, S.J.1
-
16
-
-
0036178447
-
Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins, and immnoglobulin- superfamily members
-
Juliano RL. Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins, and immnoglobulin- superfamily members. Annu Rev Pharmacol Toxicol. 2002, 42:283-323.
-
(2002)
Annu Rev Pharmacol Toxicol.
, vol.42
, pp. 283-323
-
-
Juliano, R.L.1
-
18
-
-
0033950082
-
The effects of heparin and related molecules upon the adhesion of human polymorphonuclear leucocytes to vascular endothelium in vitro
-
Lever R, Hoult JR, Page CP. The effects of heparin and related molecules upon the adhesion of human polymorphonuclear leucocytes to vascular endothelium in vitro. Br J Pharmacol. 2000, 129:533-40.
-
(2000)
Br J Pharmacol.
, vol.129
, pp. 533-540
-
-
Lever, R.1
Hoult, J.R.2
Page, C.P.3
-
19
-
-
34250634775
-
Parnaparin, a low-molecular-weight heparin, prevents P-selectin dependent formation of platelet-leukocyte aggregates in human whole blood
-
Maugeri N, Di-Fabio G, Barbanti M. Parnaparin, a low-molecular-weight heparin, prevents P-selectin dependent formation of platelet-leukocyte aggregates in human whole blood. Thromb Haemost. 2007, 97:965-73.
-
(2007)
Thromb Haemost.
, vol.97
, pp. 965-973
-
-
Maugeri, N.1
Di-Fabio, G.2
Barbanti, M.3
-
20
-
-
0033515067
-
Nonanticoagulant heparin prevents coronary endothelial dysfunction after brief ischemia-reperfusion injury in the dog
-
Kouretas PC, Kim YD, Cahill PA. Nonanticoagulant heparin prevents coronary endothelial dysfunction after brief ischemia-reperfusion injury in the dog. Circulation. 1999, 99:1062-8.
-
(1999)
Circulation.
, vol.99
, pp. 1062-1068
-
-
Kouretas, P.C.1
Kim, Y.D.2
Cahill, P.A.3
-
21
-
-
0035109328
-
The complex effects of heparins on cancer progression and metastasis in experimental studies
-
Smorenburg SM, Van Noorden CJ. The complex effects of heparins on cancer progression and metastasis in experimental studies. Parmacol Rev. 2001, 53:93-106.
-
(2001)
Parmacol Rev.
, vol.53
, pp. 93-106
-
-
Smorenburg, S.M.1
Van Noorden, C.J.2
-
22
-
-
41149176836
-
Heparin blocks the adhesion of E. coli O157:H7 to human colonic epithelial cells
-
Gu L, Wang H, Guo YL. Heparin blocks the adhesion of E. coli O157:H7 to human colonic epithelial cells. Biochem Biophys Res Commun. 2008, 369:1061-4.
-
(2008)
Biochem Biophys Res Commun.
, vol.369
, pp. 1061-1064
-
-
Gu, L.1
Wang, H.2
Guo, Y.L.3
-
23
-
-
56049115814
-
Early intravenous unfractionated heparin and mortality in septic shock
-
Zarychanski R, Doucette S, Fergusson D. Early intravenous unfractionated heparin and mortality in septic shock. Crit Care Med. 2008, 36:2973-9.
-
(2008)
Crit Care Med.
, vol.36
, pp. 2973-2979
-
-
Zarychanski, R.1
Doucette, S.2
Fergusson, D.3
-
24
-
-
18044368921
-
Selectins facilitate carcinoma metastasis and heparin can prevent them
-
Borsig L. Selectins facilitate carcinoma metastasis and heparin can prevent them. Physiology. 2004, 19:16-21.
-
(2004)
Physiology.
, vol.19
, pp. 16-21
-
-
Borsig, L.1
-
25
-
-
0036308072
-
Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and aremediated by blockade of L- and P-selectins
-
Wang L, Brown JR, Varki A. Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and aremediated by blockade of L- and P-selectins. J Clin Invest. 2002, 110:127-36.
-
(2002)
J Clin Invest.
, vol.110
, pp. 127-136
-
-
Wang, L.1
Brown, J.R.2
Varki, A.3
-
26
-
-
3142708942
-
Modified heparin inhibits P-selectin-mediated cell adhesion of human colon carcinoma cells to immobilized platelets under dynamic flow conditions
-
Wei M, Tai G, Gao Y. Modified heparin inhibits P-selectin-mediated cell adhesion of human colon carcinoma cells to immobilized platelets under dynamic flow conditions. J Biol Chem. 2004, 279:29202-10.
-
(2004)
J Biol Chem.
, vol.279
, pp. 29202-29210
-
-
Wei, M.1
Tai, G.2
Gao, Y.3
-
27
-
-
0033527375
-
Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18)
-
Peter K, Schwarz M, Conradt C. Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18). Circulation. 1999, 100:1533-9.
-
(1999)
Circulation.
, vol.100
, pp. 1533-1539
-
-
Peter, K.1
Schwarz, M.2
Conradt, C.3
-
28
-
-
0030790027
-
The potential for heparin and its derivatives in the therapy and prevention of HIV-1 infection
-
Rider CC. The potential for heparin and its derivatives in the therapy and prevention of HIV-1 infection. Glycoconj J. 1997, 14:639-42.
-
(1997)
Glycoconj J.
, vol.14
, pp. 639-642
-
-
Rider, C.C.1
-
29
-
-
19644398319
-
When heparins promote thrombosis: review of heparin-Induced thrombocytopenia
-
Jang IK, Hursting MJ. When heparins promote thrombosis: review of heparin-Induced thrombocytopenia. Circulation 2005, 111:2671-83.
-
(2005)
Circulation
, vol.111
, pp. 2671-2683
-
-
Jang, I.K.1
Hursting, M.J.2
-
30
-
-
10444223030
-
Polymorphonuclear leukocyte and monocyte activation induced by plasma from patients with heparin-induced thrombocytopenia in whole blood
-
Khairy M, Lasne D, Amelot A. Polymorphonuclear leukocyte and monocyte activation induced by plasma from patients with heparin-induced thrombocytopenia in whole blood. Thromb Haemost. 2004, 92:1411-9.
-
(2004)
Thromb Haemost.
, vol.92
, pp. 1411-1419
-
-
Khairy, M.1
Lasne, D.2
Amelot, A.3
-
31
-
-
0035099843
-
Heparin modulates integrin function in human platelets
-
Sobel M, Fish WR, Toma N. Heparin modulates integrin function in human platelets. J Vasc Surg. 2001, 33:587-95.
-
(2001)
J Vasc Surg.
, vol.33
, pp. 587-595
-
-
Sobel, M.1
Fish, W.R.2
Toma, N.3
-
32
-
-
0033614851
-
Thrombin-induced platelet activation is inhibited by high- and low-molecular-weight heparin
-
De Candia E, De Cristofaro R, Landolfi R. Thrombin-induced platelet activation is inhibited by high- and low-molecular-weight heparin. Circulation. 1999, 99:3308-14.
-
(1999)
Circulation.
, vol.99
, pp. 3308-3314
-
-
De Candia, E.1
De Cristofaro, R.2
Landolfi, R.3
-
34
-
-
56449095100
-
Control of growth factor networks by heparan sulfate proteoglycans
-
Forsten-Williams K, Chu CL, Fannon M. Control of growth factor networks by heparan sulfate proteoglycans. Ann Biomed Eng. 2008, 36:2134-48.
-
(2008)
Ann Biomed Eng.
, vol.36
, pp. 2134-2148
-
-
Forsten-Williams, K.1
Chu, C.L.2
Fannon, M.3
-
35
-
-
0034326271
-
Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro
-
Collen A, Smorenburg SM, Peters E. Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro. Cancer Res. 2000, 60:6196-200.
-
(2000)
Cancer Res.
, vol.60
, pp. 6196-6200
-
-
Collen, A.1
Smorenburg, S.M.2
Peters, E.3
-
36
-
-
14644395531
-
Suppression of Ca2+ influx by unfractionated heparin in non-excitable intact cells via multiple mechanisms
-
Nemeth K, Kurucz I. Suppression of Ca2+ influx by unfractionated heparin in non-excitable intact cells via multiple mechanisms. Biochem Pharmacol. 2005, 69:929-40.
-
(2005)
Biochem Pharmacol.
, vol.69
, pp. 929-940
-
-
Nemeth, K.1
Kurucz, I.2
-
37
-
-
0023818963
-
Heparin inhibits IP3-induced Ca2+ release in permeabilized pancreatic beta-cells
-
Nilsson T, Zwiller J, Boynton AL. Heparin inhibits IP3-induced Ca2+ release in permeabilized pancreatic beta-cells. FEBS Lett. 1988, 229:211-4.
-
(1988)
FEBS Lett.
, vol.229
, pp. 211-214
-
-
Nilsson, T.1
Zwiller, J.2
Boynton, A.L.3
-
38
-
-
39149098478
-
Heparan sulfate proteoglycans and their binding proteins in embryo implantation and placentation
-
Kirn-Safran CB, D'Souza SS, Carson DD. Heparan sulfate proteoglycans and their binding proteins in embryo implantation and placentation. Semin Cell Dev Biol. 2008, 19:187-93.
-
(2008)
Semin Cell Dev Biol.
, vol.19
, pp. 187-193
-
-
Kirn-Safran, C.B.1
D'Souza, S.S.2
Carson, D.D.3
-
39
-
-
34247610845
-
Heparan sulphate proteoglycans fine-tune mammalian physiology
-
Bishop JR, Schuksz M, Esko JD. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature. 2007, 446:1030-7.
-
(2007)
Nature.
, vol.446
, pp. 1030-1037
-
-
Bishop, J.R.1
Schuksz, M.2
Esko, J.D.3
-
40
-
-
15244364003
-
Heparan sulfate-protein interactions: therapeutic potential through structure-function insights
-
Coombe DR, Kett WC. Heparan sulfate-protein interactions: therapeutic potential through structure-function insights. Cell Mol Life Sci. 2005, 62:410-24.
-
(2005)
Cell Mol Life Sci.
, vol.62
, pp. 410-424
-
-
Coombe, D.R.1
Kett, W.C.2
-
41
-
-
0034852346
-
Heparan sulfate: anchor for viral intruders?
-
Spilmann D. Heparan sulfate: anchor for viral intruders?. Biochimie. 2001, 83:811-7.
-
(2001)
Biochimie.
, vol.83
, pp. 811-817
-
-
Spilmann, D.1
-
42
-
-
35148851934
-
The binding of human betacellulin to heparin, heparan sulfate and related polysaccharides
-
Mummery RS, Mulloy B, Rider CC. The binding of human betacellulin to heparin, heparan sulfate and related polysaccharides. Glycobiology. 2007, 17:1094-103.
-
(2007)
Glycobiology.
, vol.17
, pp. 1094-1103
-
-
Mummery, R.S.1
Mulloy, B.2
Rider, C.C.3
-
43
-
-
33746614761
-
Interactions between heparan sulfate and proteins: the concept of specificity
-
Kreuger J, Spillmann D, Li JP. Interactions between heparan sulfate and proteins: the concept of specificity. J Cell Biol. 2006, 174:323-7.
-
(2006)
J Cell Biol.
, vol.174
, pp. 323-327
-
-
Kreuger, J.1
Spillmann, D.2
Li, J.P.3
-
44
-
-
0035793619
-
Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans
-
Tyagi M, Rusnati M, Presta M. Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem. 2001, 276:3254-61.
-
(2001)
J Biol Chem.
, vol.276
, pp. 3254-3261
-
-
Tyagi, M.1
Rusnati, M.2
Presta, M.3
-
45
-
-
0035984272
-
Heparin and heparan sulfate: structure and function
-
Rabenstein DL. Heparin and heparan sulfate: structure and function. Nat Prod Rep. 2002, 19:312-31.
-
(2002)
Nat Prod Rep.
, vol.19
, pp. 312-331
-
-
Rabenstein, D.L.1
-
46
-
-
33748048179
-
The role of heparan sulfate in inflammation
-
Parish CR. The role of heparan sulfate in inflammation. Nature Rev Immunol. 2006, 6:633-43.
-
(2006)
Nature Rev Immunol.
, vol.6
, pp. 633-643
-
-
Parish, C.R.1
-
48
-
-
7944230119
-
Heparan sulfate proteoglycans and heparanase-partners in osteolytic tumor growth and metastasis
-
Sanderson RD, Yang Y, Suva LJ. Heparan sulfate proteoglycans and heparanase-partners in osteolytic tumor growth and metastasis. Matrix Biol. 2004, 23:341-52.
-
(2004)
Matrix Biol.
, vol.23
, pp. 341-352
-
-
Sanderson, R.D.1
Yang, Y.2
Suva, L.J.3
-
49
-
-
34447287858
-
Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate
-
Vlodavsky I, Ilan N, Naggi A. Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate. Curr Pharm Des. 2007, 13:2057-73.
-
(2007)
Curr Pharm Des.
, vol.13
, pp. 2057-2073
-
-
Vlodavsky, I.1
Ilan, N.2
Naggi, A.3
-
50
-
-
0025272649
-
Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity
-
Lider O, Mekori YA, Miller T. Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity. Eur J Immunol. 1990, 20:493-9.
-
(1990)
Eur J Immunol.
, vol.20
, pp. 493-499
-
-
Lider, O.1
Mekori, Y.A.2
Miller, T.3
-
51
-
-
54849163100
-
Small molecules for interference with cell-cell-communication systems in Gram-negative bacteria
-
Janssens JC, De Keersmaecker SC, De Vos DE. Small molecules for interference with cell-cell-communication systems in Gram-negative bacteria. Curr Med Chem. 2008, 15:2144-56.
-
(2008)
Curr Med Chem.
, vol.15
, pp. 2144-2156
-
-
Janssens, J.C.1
De Keersmaecker, S.C.2
De Vos, D.E.3
-
52
-
-
0242385433
-
Enzymatic synthesis of antithrombinIII-binding heparan sulfate pentasaccharide
-
Kuberan B, Lech MZ, Beeler DL. Enzymatic synthesis of antithrombinIII-binding heparan sulfate pentasaccharide. Nat Biotechnol. 2003, 21:1343-6.
-
(2003)
Nat Biotechnol.
, vol.21
, pp. 1343-1346
-
-
Kuberan, B.1
Lech, M.Z.2
Beeler, D.L.3
-
53
-
-
34047121229
-
The heparanome-the enigma of encoding and decoding heparan sulfate sulfation
-
Lamanna WC, Kalus I, Padva M. The heparanome-the enigma of encoding and decoding heparan sulfate sulfation. J Biotechnol. 2007, 129:290-307.
-
(2007)
J Biotechnol.
, vol.129
, pp. 290-307
-
-
Lamanna, W.C.1
Kalus, I.2
Padva, M.3
|